We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Pilot Study of Celecoxib in Patients With Grade 2 or 3 Uterine Cancers

This study has been terminated.
(Due to reported toxicity of Celecoxib at high doses)
Sponsor:
ClinicalTrials.gov Identifier:
NCT00231829
First Posted: October 4, 2005
Last Update Posted: April 24, 2012
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Pharmacia
Information provided by (Responsible Party):
Mark H. Einstein, Montefiore Medical Center
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: March 2004
  Primary Completion Date: March 2004 (Final data collection date for primary outcome measure)